Genetic Analysis Algorithm for the Study of Patients with Multiple Congenital Anomalies and Isolated Congenital Heart Disease.

Congenital anomalies (CA) affect 3-5% of newborns, representing the second-leading cause of infant mortality in Argentina. Multiple congenital anomalies (MCA) have a prevalence of 2.26/1000 births in newborns, while congenital heart diseases (CHD) are the most frequent CA with a prevalence of 4.06/1000 births. The aim of this study was to identify the genetic causes in Argentinian patients with MCA and isolated CHD. We recruited 366 patients (172 with MCA and 194 with isolated CHD) born between June 2015 and August 2019 at public hospitals. DNA from peripheral blood was obtained from all patients, while karyotyping was performed in patients with MCA. Samples from patients presenting conotruncal CHD or DiGeorge phenotype (n = 137) were studied using MLPA. Ninety-three samples were studied by array-CGH and 18 by targeted or exome next-generation sequencing (NGS). A total of 240 patients were successfully studied using at least one technique. Cytogenetic abnormalities were observed in 13 patients, while 18 had clinically relevant imbalances detected by array-CGH. After MLPA, 26 patients presented 22q11 deletions or duplications and one presented a TBX1 gene deletion. Following NGS analysis, 12 patients presented pathogenic or likely pathogenic genetic variants, five of them, found in KAT6B, SHH, MYH11, MYH7 and EP300 genes, are novel. Using an algorithm that combines molecular techniques with clinical and genetic assessment, we determined the genetic contribution in 27.5% of the analyzed patients.

Genetic characterization of a large cohort of Argentine 21-hydroxylase Deficiency.

CONTEXT: 21-hydroxylase deficiency is the most common cause of Congenital Adrenal Hyperplasia. It presents as severe or classical forms-salt wasting and simple virilizing-and a mild or nonclassical (NC). Several studies have reported the frequency of pathogenic variants in different populations, although few of them included a large number of NC patients. OBJECTIVE: To analyse the CYP21A2 gene defects in a large cohort of Argentine patients. DESIGN: Molecular characterization of 628 patients (168 classical, 460 nonclassical, representing 1203 nonrelated alleles), 398 relatives, 126 partners. METHODS: Genetic variants were assessed by allele-specific PCR, PCR-RFLP or direct sequencing. Deletions, duplications and large gene conversions (LGC) were studied by Southern blot/MLPA or long-range PCR. Biological implications of novel variants were analysed by structure-based in silico studies. RESULTS: The most frequent pathogenic variants were p.V282L (58%) in NC alleles and c.293-13C>G (31.8%) and p.I173N (21.1%) in classical. Deletions and LGC were found at low frequency (6.2%), 57 alleles had rare pathogenic variants, and 3 had novel variants: p.(S166F); p.(P189R), p.(R436L). Genotype-phenotype correlation was observed in 98.6% of the cases, 11 asymptomatic first-degree relatives had pathogenic variants in both alleles, and 21/126 partners were carriers. CONCLUSIONS: We conducted a comprehensive genetic characterization of the largest cohort of 21-hydroxylase patients from the region. In particular, we add to the molecular characterization of a large number of NC patients and to the estimation of the disease carrier's frequency in our population.

CYP21A2 mutation update: Comprehensive analysis of databases and published genetic variants.

Congenital adrenal hyperplasia (CAH) is a group of autosomal recessive disorders of adrenal steroidogenesis. Disorders in steroid 21-hydroxylation account for over 95% of patients with CAH. Clinically, the 21-hydroxylase deficiency has been classified in a broad spectrum of clinical forms, ranging from severe or classical, to mild late onset or non-classical. Known allelic variants in the disease causing CYP21A2 gene are spread among different sources. Until recently, most variants reported have been identified in the clinical setting, which presumably bias described variants to pathogenic ones, as those found in the CYPAlleles database. Nevertheless, a large number of variants are being described in massive genome projects, many of which are found in dbSNP, but lack functional implications and/or their phenotypic effect. In this work, we gathered a total of 1,340 GVs in the CYP21A2 gene, from which 899 variants were unique and 230 have an effect on human health, and compiled all this information in an integrated database. We also connected CYP21A2 sequence information to phenotypic effects for all available mutations, including double mutants in cis. Data compiled in the present work could help physicians in the genetic counseling of families affected with 21-hydroxylase deficiency.

Structure-based activity prediction of CYP21A2 stability variants: A survey of available gene variations.

Congenital adrenal hyperplasia due to 21-hydroxylase deficiency accounts for 90-95% of CAH cases. In this work we performed an extensive survey of mutations and SNPs modifying the coding sequence of the CYP21A2 gene. Using bioinformatic tools and two plausible CYP21A2 structures as templates, we initially classified all known mutants (n = 343) according to their putative functional impacts, which were either reported in the literature or inferred from structural models. We then performed a detailed analysis on the subset of mutations believed to exclusively impact protein stability. For those mutants, the predicted stability was calculated and correlated with the variant's expected activity. A high concordance was obtained when comparing our predictions with available in vitro residual activities and/or the patient's phenotype. The predicted stability and derived activity of all reported mutations and SNPs lacking functional assays (n = 108) were assessed. As expected, most of the SNPs (52/76) showed no biological implications. Moreover, this approach was applied to evaluate the putative synergy that could emerge when two mutations occurred in cis. In addition, we propose a putative pathogenic effect of five novel mutations, p.L107Q, p.L122R, p.R132H, p.P335L and p.H466fs, found in 21-hydroxylase deficient patients of our cohort.

Misregulation effect of a novel allelic variant in the Z promoter region found in cis with the CYP21A2 p.P482S mutation: implications for 21-hydroxylase deficiency.

The aim of the current study was to search for the presence of genetic variants in the CYP21A2 Z promoter regulatory region in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Screening of the 10 most frequent pseudogene-derived mutations was followed by direct sequencing of the entire coding sequence, the proximal promoter, and a distal regulatory region in DNA samples from patients with at least one non-determined allele. We report three non-classical patients that presented a novel genetic variant-g.15626A>G-within the Z promoter regulatory region. In all the patients, the novel variant was found in cis with the mild, less frequent, p.P482S mutation located in the exon 10 of the CYP21A2 gene. The putative pathogenic implication of the novel variant was assessed by in silico analyses and in vitro assays. Topological analyses showed differences in the curvature and bendability of the DNA region bearing the novel variant. By performing functional studies, a significantly decreased activity of a reporter gene placed downstream from the regulatory region was found by the G transition. Our results may suggest that the activity of an allele bearing the p.P482S mutation may be influenced by the misregulated CYP21A2 transcriptional activity exerted by the Z promoter A>G variation.

Caracterización molecular de pacientes con deficiencia de 21-hidroxilasa en Argentina / Molecular characterization of patients with 21-hydroxylase deficiency in Argentina

INTRODUCCION: La hiperplasia suprarrenal congénita se caracteriza por la disminución en la síntesis de cortisol por la glándula adrenal. El 95% de los casos se debe a la deficiencia en la enzima 21-hidroxilasa. La enzima es codificada por el gen CYP21A2, ubicado dentro del módulo RCCX; su expresión está modulada por dos regiones río arriba del gen.OBJETIVO: Obtener la caracterización molecular de la región RCCX y estudiar posibles variaciones de secuencia en las dos regiones regulatorias distales de la transcripción del gen, en pacientes de Argentina.METODOS: La caracterización molecular de la región RCCX se llevó a cabo mediante la técnica de Southern Blot, usando las restricciones con las enzimas Taq I y Bgl II y sondas para los genes CYP21, TNX y C4. El estudio de las regiones regulatorias de la transcripción se realizó por secuenciación automática de los fragmentos de interés.RESULTADOS: Se identificaron ocho haplotipos diferentes de la región RCCX y se encontró una variante de secuencia en cada región regulatoria estudiada.CONCLUSIONES: Las técnicas utilizadas fueron adecuadas para lograr los objetivos propuestos. La caracterización molecular de la región RCCX permitió evidenciar una elevada variabilidad en la composición génica y modular de la región. Por su parte ,los resultados de estudios de bioinformática indicarían que la variante alélica hallada en una de las regiones regulatorias podría modular la expresión del gen CYP21A2. Ambos estudios constituyes los reportes más detallados de la caracterización de ambas regiones en pacientes argentinos.

INTRODUCTION: The congenital adrenal hyperplasia is characterized by decreased synthesis of cortisol by the adrenal gland. 95% of the cases are fue to deficiency in the exime 21-hydroxylase. The enzyme is encoded by the CYP21A2 gene, located within the RCCX module; its expression is modulated by two regions upstream of the gene.OBJECTIVE: To obtain the molecular characterization of the RCCX region, where the CYP21A2 gene is located. Also, to study possible sequence variations in the two distal regulatory regions of gene transportation in patients of Argentina.METHODS: The molecular characterization of the RCCX region was done by Southern blot technique, using the restrictions with enzymes Taq I and Bgl II and probes for genes CYP21, TNX and C4. The study of transcriptional regulatory regions was performed by automatic sequencing of fragments of interest.RESULTS: Eight different haplotypes were identifies in the RCCX region, finding a sequence variant in each regulatory region studied.CONCLUSIONS: The techniques used were adequate to achieve the proposed objectives. The molecular characterization of the RCCX region showed a high variability in gene and modular composition. Moreover, results from bioinformatics studies indicate that the allelic variant found in one of the regulatory regions could modulate the expression of CYP21A2 gene. Both studies constitute the most detailed reports characterizing the two regions in Argentinean patients.

Caracterización molecular de pacientes con deficiencia de 21-hidroxilasa en Argentina / Molecular characterization of patients with 21-hydroxylase deficiency in Argentina

INTRODUCCION: La hiperplasia suprarrenal congénita se caracteriza por la disminución en la síntesis de cortisol por la glándula adrenal. El 95% de los casos se debe a la deficiencia en la enzima 21-hidroxilasa. La enzima es codificada por el gen CYP21A2, ubicado dentro del módulo RCCX; su expresión está modulada por dos regiones río arriba del gen.OBJETIVO: Obtener la caracterización molecular de la región RCCX y estudiar posibles variaciones de secuencia en las dos regiones regulatorias distales de la transcripción del gen, en pacientes de Argentina.METODOS: La caracterización molecular de la región RCCX se llevó a cabo mediante la técnica de Southern Blot, usando las restricciones con las enzimas Taq I y Bgl II y sondas para los genes CYP21, TNX y C4. El estudio de las regiones regulatorias de la transcripción se realizó por secuenciación automática de los fragmentos de interés.RESULTADOS: Se identificaron ocho haplotipos diferentes de la región RCCX y se encontró una variante de secuencia en cada región regulatoria estudiada.CONCLUSIONES: Las técnicas utilizadas fueron adecuadas para lograr los objetivos propuestos. La caracterización molecular de la región RCCX permitió evidenciar una elevada variabilidad en la composición génica y modular de la región. Por su parte ,los resultados de estudios de bioinformática indicarían que la variante alélica hallada en una de las regiones regulatorias podría modular la expresión del gen CYP21A2. Ambos estudios constituyes los reportes más detallados de la caracterización de ambas regiones en pacientes argentinos.

INTRODUCTION: The congenital adrenal hyperplasia is characterized by decreased synthesis of cortisol by the adrenal gland. 95% of the cases are fue to deficiency in the exime 21-hydroxylase. The enzyme is encoded by the CYP21A2 gene, located within the RCCX module; its expression is modulated by two regions upstream of the gene.OBJECTIVE: To obtain the molecular characterization of the RCCX region, where the CYP21A2 gene is located. Also, to study possible sequence variations in the two distal regulatory regions of gene transportation in patients of Argentina.METHODS: The molecular characterization of the RCCX region was done by Southern blot technique, using the restrictions with enzymes Taq I and Bgl II and probes for genes CYP21, TNX and C4. The study of transcriptional regulatory regions was performed by automatic sequencing of fragments of interest.RESULTS: Eight different haplotypes were identifies in the RCCX region, finding a sequence variant in each regulatory region studied.CONCLUSIONS: The techniques used were adequate to achieve the proposed objectives. The molecular characterization of the RCCX region showed a high variability in gene and modular composition. Moreover, results from bioinformatics studies indicate that the allelic variant found in one of the regulatory regions could modulate the expression of CYP21A2 gene. Both studies constitute the most detailed reports characterizing the two regions in Argentinean patients.